Key statistics
As of last trade Bausch + Lomb Corp (BLCO:NYQ) traded at 18.22, -3.67% below its 52-week high of 18.92, set on Feb 25, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 17.89 |
|---|---|
| High | 18.22 |
| Low | 17.52 |
| Bid | 18.00 |
| Offer | 18.24 |
| Previous close | 18.41 |
| Average volume | 543.83k |
|---|---|
| Shares outstanding | 354.29m |
| Free float | 38.86m |
| P/E (TTM) | -- |
| Market cap | 6.48bn USD |
| EPS (TTM) | -1.02 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 14:40 GMT.
More ▼
Press releases
- Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
- Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
- Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
- Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
- Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
- Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Bausch + Lomb Announces Two Board of Directors Appointments
- Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
More ▼
